Windtree Therapeutics Inc Asset Turnover Ratio (WINT), as of third quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Windtree Therapeutics Inc  (WINT)
 

Windtree Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2025, Windtree Therapeutics Inc has not recorded any assets.
Visit Windtree Therapeutics Inc Balance sheet

Within sector Windtree Therapeutics Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2025 compared to previous quarter at no. .

Asset Turnover Ratio Definition



WINT Asset Turnover Ratio (Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
Y / Y Asset Change -47.49 % 11.83 % -11.08 % -14.53 % -15.88 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) - - 0.01 - -
WINT's Total Ranking # # # # #
Seq. Asset Change -49.76 % 18.9 % -3.77 % -8.64 % 6.99 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Assets at quarter ending Sep 30 2025
Abcellera Biologics Inc   0.03 $ 35.323  Millions$ 1,365.704  Millions
Mangoceuticals Inc   0.03 $ 0.467  Millions$ 18.625  Millions
Uniqure N v   0.02 $ 15.751  Millions$ 658.803  Millions
Proqr Therapeutics N v   0.02 $ 3.368  Millions$ 146.653  Millions
Aligos Therapeutics Inc   0.02 $ 2.646  Millions$ 116.316  Millions
Envoy Medical Inc   0.02 $ 0.208  Millions$ 10.001  Millions
Bioxcel Therapeutics Inc   0.02 $ 0.752  Millions$ 36.871  Millions
Prophase Labs Inc   0.02 $ 1.071  Millions$ 55.263  Millions
Prime Medicine Inc   0.02 $ 5.977  Millions$ 322.423  Millions
Fate Therapeutics Inc   0.02 $ 7.137  Millions$ 388.667  Millions
Aim Immunotech Inc   0.02 $ 0.112  Millions$ 6.120  Millions
Crispr Therapeutics Ag  0.02 $ 38.337  Millions$ 2,170.789  Millions
Vivos Inc  0.02 $ 0.046  Millions$ 2.652  Millions
Ataibeckley Inc   0.02 $ 3.018  Millions$ 196.049  Millions
Hcw Biologics Inc   0.02 $ 0.422  Millions$ 27.719  Millions
Vir Biotechnology Inc   0.01 $ 16.860  Millions$ 1,229.631  Millions
Vivosim Labs Inc   0.01 $ 0.140  Millions$ 10.666  Millions
Atrium Therapeutics Inc   0.01 $ 20.868  Millions$ 1,631.526  Millions
Absci Corp  0.01 $ 2.815  Millions$ 225.235  Millions
Nakamoto Inc   0.01 $ 1.980  Millions$ 177.138  Millions
Lyra Therapeutics Inc   0.01 $ 0.600  Millions$ 54.736  Millions
Silo Pharma Inc  0.01 $ 0.072  Millions$ 6.587  Millions
Rallybio Corporation  0.01 $ 0.638  Millions$ 61.189  Millions
Rafael Holdings Inc  0.01 $ 1.029  Millions$ 102.655  Millions
Co diagnostics Inc   0.01 $ 0.508  Millions$ 52.589  Millions
Clene Inc   0.01 $ 0.214  Millions$ 24.272  Millions
Vistagen Therapeutics Inc   0.01 $ 0.721  Millions$ 89.462  Millions
Solana Company  0.01 $ 0.941  Millions$ 122.710  Millions
Dianthus Therapeutics Inc   0.01 $ 3.078  Millions$ 406.527  Millions
Upstream Bio Inc   0.01 $ 2.799  Millions$ 437.401  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.